Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia.
10.4093/dmj.2016.40.6.433
- Author:
Wei Jei LEE
1
;
Lwin AUNG
Author Information
1. Department of Surgery, Min-Sheng General Hospital, National Taiwan University, Taoyuan, Taiwan. wjlee_obessurg_tw@yahoo.com.tw
- Publication Type:Clinical Trial ; Review
- Keywords:
Asian continental ancestry group;
Bariatric surgery;
Diabetes mellitus, type 2;
Obesity
- MeSH:
Adult;
Asia*;
Asian Continental Ancestry Group;
Bariatric Surgery*;
Diabetes Mellitus, Type 2*;
Diabetic Nephropathies;
Global Health;
Humans;
Incidence;
Obesity;
Patient Selection
- From:Diabetes & Metabolism Journal
2016;40(6):433-443
- CountryRepublic of Korea
- Language:English
-
Abstract:
Type 2 diabetes mellitus (T2DM) is a current global health priority and Asia is the epicenter of this epidemic disease. Unlike in the west, where older population is most affected, the burden of diabetes in Asian countries is disproportionately high in young to middle-age adults. The incidence of diabetic nephropathy is alarmingly high in patients with early onset T2DM, especially in those with poor glycemic control. How to control this chronic and debilitating disease is currently a very important health issue in Asia. Bariatric surgery has proven successful in treating not just obesity but also T2DM in morbid obese patients (body mass index [BMI] >35 kg/m²). Gastrointestinal metabolic surgery recently has been proposed as a new treatment modality for obesity related T2DM for patients with BMI <35 kg/m². Many studies from Asia reported promising results of metabolic surgery to treat obese patients with T2DM which is not well controlled. It has been demonstrated that changes in gastrointestinal hormone secretion after gastrointestinal surgery would favor an early improvement of T2DM in Asians. New procedures have also been designed and proposed specifically for the treatment of diabetes in Asia. This article examines clinical trial data and accepted algorithms with a view toward elucidating the application of metabolic surgery for the treatment of T2DM in the Asia. We propose a systematic approach to surgical treatment, addressing current evidences, patient selection, procedure of choice, and timing and guideline for new procedures.
